1. Home
  2. ETNB vs DDL Comparison

ETNB vs DDL Comparison

Compare ETNB & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • DDL
  • Stock Information
  • Founded
  • ETNB 2018
  • DDL 2014
  • Country
  • ETNB United States
  • DDL China
  • Employees
  • ETNB N/A
  • DDL N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • ETNB Health Care
  • DDL Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • DDL Nasdaq
  • Market Cap
  • ETNB 867.4M
  • DDL 745.0M
  • IPO Year
  • ETNB 2019
  • DDL 2021
  • Fundamental
  • Price
  • ETNB $7.93
  • DDL $4.00
  • Analyst Decision
  • ETNB Buy
  • DDL Sell
  • Analyst Count
  • ETNB 7
  • DDL 1
  • Target Price
  • ETNB $30.33
  • DDL $1.15
  • AVG Volume (30 Days)
  • ETNB 901.8K
  • DDL 1.6M
  • Earning Date
  • ETNB 11-07-2024
  • DDL 11-06-2024
  • Dividend Yield
  • ETNB N/A
  • DDL N/A
  • EPS Growth
  • ETNB N/A
  • DDL N/A
  • EPS
  • ETNB N/A
  • DDL 0.13
  • Revenue
  • ETNB N/A
  • DDL $3,158,412,712.00
  • Revenue This Year
  • ETNB N/A
  • DDL $11.04
  • Revenue Next Year
  • ETNB $133.30
  • DDL $10.96
  • P/E Ratio
  • ETNB N/A
  • DDL $30.56
  • Revenue Growth
  • ETNB N/A
  • DDL 4.61
  • 52 Week Low
  • ETNB $7.00
  • DDL $1.07
  • 52 Week High
  • ETNB $16.63
  • DDL $4.60
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 42.09
  • DDL 55.14
  • Support Level
  • ETNB $9.00
  • DDL $3.85
  • Resistance Level
  • ETNB $10.01
  • DDL $4.32
  • Average True Range (ATR)
  • ETNB 0.80
  • DDL 0.34
  • MACD
  • ETNB -0.10
  • DDL -0.02
  • Stochastic Oscillator
  • ETNB 8.52
  • DDL 47.84

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: